Navigation Links
Study Finds Heart Failure Drug Ineffective
Date:7/6/2011

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, July 6 (HealthDay News) -- The heart failure drug Natrecor (nesiritide) is ineffective and linked to increased rates of potentially dangerous low blood pressure, a new study finds.

The intravenous drug was approved in 2001 to help heart failure patients breathe more easily when they were struggling with severe shortness of breath. But the drug had no significant effect on breathing difficulties or other disease-related problems and may also result in low blood pressure, according to the researchers.

The report was published in the July 7 issue of the New England Journal of Medicine.

The study "doesn't show any use for nesiritide, that's for sure," said Dr. Eric J. Topol, professor of translational genomics at the Scripps Research Institute in La Jolla, Calif., and author of an accompanying journal editorial.

Topol noted nesiritide isn't used much, because it is considered no better than some other less expensive drugs. According to Topol, who was not involved in the study, nesiritide can cost $500 to $700 per infusion. Other drugs such as Lasix (furosemide),and nitroglycerin given intravenously cost substantially less and have proven efficacy, he said.

However, Topol's real concerns are much broader. "It shouldn't take this long to find out the truth about a drug," he said. "There should be a drive to get as much information about a drug as early as possible and not have a lost decade, as we saw here."

One of the study authors noted that the research documented the potential risks and benefits of the drug in people with heart failure who have severe trouble breathing -- a condition called dyspnea -- because their disease is worsening.

"This trial demonstrated that nesiritide did not cause an increase in the rate of death or worsening of renal function and that prior concerns regarding the safety of nesiritide were unfounded," said st
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. New study: Women less likely than men to fake soccer injuries
2. Long Commutes for Pilots May Hamper Flying Performance: Study
3. Study Finds Most Urgent Angioplasties Warranted
4. Mammogram Schedule Should Be Customized, Study Finds
5. Small, Rural Hospitals Provide a Lower Quality of Care: Study
6. Infants learn to transfer knowledge by 16 months, study finds
7. Massage Beats Meds for Lower Back Pain, Study Says
8. Radiation rates for breast cancer may be underestimated, U-M study finds
9. Experimental Drug Bests Chemo in Non-Small Cell Lung Cancer Study
10. Tots Who Are Late Talkers Typically Turn Out Fine: Study
11. Stop-Smoking Drug Chantix Ups Risk of Heart Problems: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Finds Heart Failure Drug Ineffective
(Date:1/22/2015)... Hawley, PA (PRWEB) January 22, 2015 Woodloch ... Pocono Mountains, has been selected by TripAdvisor as the number ... and the 6th best in the world for their annual ... online travel community . The website is home to ...
(Date:1/22/2015)... a seasoned and trusted leader who consistently delivers trendy dresses ... it lead the wedding dress industry into the future. Today, ... the global market. , “The CEO of VogueQueen is uniquely ... continuing the goal of operational excellence and giving back to ...
(Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2
... News) -- Rheumatoid arthritis patients who believe in their ... -- are more likely to reach those objectives, researchers ... who achieve their physical activity goals have lower levels ... Researchers in the Netherlands conducted an initial assessment ...
... faculty researchers and clinicians with expertise in polypharmacy, ... geriatric researcher at a free conference examining Alzheimer,s ... Medicine and Nursing join with the Greater Kentucky ... to present "The Journey: Alzheimer,s Disease and Caregiving" ...
... 2011) Bone marrow transplantation with genetically modified cells ... study led by Dr. Vivek Rangnekar, associate director of ... University of Kentucky. Bone marrow, a spongy tissue ... including leukocytes, erythrocytes and platelets. In the cover story ...
... , WEDNESDAY, Aug. 24 (HealthDay News) -- High ... fatal abnormal heart rhythms and should no longer be ... said Wednesday. Doses of Celexa (citalopram hydrobromide) greater ... the electrical activity of the heart, which can lead ...
... Aug. 24 (HealthDay News) -- U.S. teens who use social networking ... drugs and alcohol than teens with little exposure to such media, ... youths from around the nation aged 12 to 17 and about ... of teens said they used social networking sites. Social network ...
... Ont., Aug 24, 2011 More than eight out of ... and elsewhere have at least one chronic health condition and ... who are "vulnerably housed"meaning they live in unsafe, unstable or ... the survey found. The underlying cause for these health ...
Cached Medicine News:Health News:UofL experts featured at free Alzheimer's disease conference Sept. 17 2Health News:Teen Drinking, Smoking Higher Among Facebook Users: Survey 2Health News:Teen Drinking, Smoking Higher Among Facebook Users: Survey 3Health News:Study: 85 percent of homeless people have chronic health conditions 2
(Date:1/23/2015)...  Mallinckrodt plc (NYSE: MNK ) announced today ... repurchase program. The open-ended authorization permits the company to ... shares. "Funding additional initiatives and seeking ... continue to pursue a range of focused growth strategies," ...
(Date:1/22/2015)... 2015  ViewRay™, a privately held medical device company, announced ... agreement with ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) ... treatment of cancer in Japan . ... first and only MRI-guided radiation therapy system that images ...
(Date:1/22/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the ... therapies for cardiovascular disease and overall health is pleased to ... 2014 and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... Concentric Medical,Inc., the global leader in devices for ... results of its Multi MERCI trial will be,published in ... The,Multi MERCI trial was the second trial studying safety ... that is delivered,into the brain and is designed to ...
... ... investigator interest, SEATTLE, March 6 ... that its investigational drug,pixantrone will be studied in a multicenter ... Belgium, which sponsors a,consortium of centers involved in studying new ...
Cached Medicine Technology:Multi Merci Trial Results Published in Peer Reviewed Journal 2Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis 2Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis 3Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis 4
Detection of Lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasma with heparin inhibitor; PTT-LS reagent of cephalin and particulate siliceous activator;all fre...
Colorimetric Assay of Protein C Activity by STA© Analyzers. Highly purified extract of Agkistrodon c. contortrix venom for specific activation of protein C, with an activator selected specially ...
Immuno-turbidimetric assay for Free Protein Sby STA© Analyzers. Suspension of microparticles coated with monoclonal antibodies to Free Protein S....
Substrate Plasma for Factor V Assay by STA© Analyzers. Freeze-dried human plasma, artificially depleted of factor V....
Medicine Products: